Carolinas Wealth Consulting’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18
Closed -$1.3K 1050
2024
Q4
$1.3K Hold
18
﹤0.01% 901
2024
Q3
$1.47K Hold
18
﹤0.01% 865
2024
Q2
$1.34K Hold
18
﹤0.01% 865
2024
Q1
$1.4K Hold
18
﹤0.01% 842
2023
Q4
$1.29K Sell
18
-93
-84% -$6.47K ﹤0.01% 798
2023
Q3
$7.34K Sell
111
-24
-18% -$1.81K ﹤0.01% 558
2023
Q2
$10.9K Sell
135
-50
-27% -$4.09K ﹤0.01% 582
2023
Q1
$14.9K Sell
185
-95
-34% -$7.65K ﹤0.01% 540
2022
Q4
$20.9K Hold
280
﹤0.01% 489
2022
Q3
$18K Hold
280
﹤0.01% 459
2022
Q2
$19K Buy
280
+95
+51% +$7.05K ﹤0.01% 458
2022
Q1
$14K Hold
185
﹤0.01% 553
2021
Q4
$14K Hold
185
﹤0.01% 565
2021
Q3
$14K Hold
185
﹤0.01% 540
2021
Q2
$12K Hold
185
﹤0.01% 586
2021
Q1
$14K Sell
185
-36
-16% -$2.73K ﹤0.01% 577
2020
Q4
$16K Hold
221
﹤0.01% 512
2020
Q3
$15K Buy
221
+203
+1,128% +$12.8K 0.01% 426
2020
Q2
$1K Buy
+18
New +$883 ﹤0.01% 571

Other funds holding HOLX

Carolinas Wealth Consulting's HOLX Position: Q1 2025 in Review

Carolinas Wealth Consulting sold out of Hologic (HOLX) in Q1 2025, closing a stake of 18 shares — an estimated $1.3K sold.

Carolinas Wealth Consulting first reported a position in HOLX in Q2 2020 and held it in 19 quarters. The position peaked at $20.9K in Q4 2022. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Carolinas Wealth Consulting reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 18 Hologic shares in Q1 2025, an estimated $1.3K.
  • Carolinas Wealth Consulting first reported a position in Hologic in Q2 2020 and held it in 19 quarters.
  • Carolinas Wealth Consulting's Hologic position peaked at $20.9K in Q4 2022.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2025, filed 14 Aug 2025.